Moreover, in accordance with the epigenetic defects seen in VPS39-silenced cells, individuals with T2D had higher DNMT levels and global DNA methylation in myoblasts, as well as aberrant remodeling of the DNA methylome during myogenesis. The gene discussed is VPS39; the disease is type 2 diabetes mellitus.